Changes over time in post-seroconversion CD4 cell counts in the Italian HIV-Seroconversion Study: 1985-2002

AIDS

Volumn 19, Issue 3, 2005, Pages 331-335

  Dorrucci, Maria ^a   Phillips, Andrew N ^b   Longo, Benedetta ^a   Rezza, Giovanni ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

CD4; HIV seroconversion; Temporal trend

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; FEMALE; GENDER; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ITALY; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SEROCONVERSION; VIRUS TRANSMISSION;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CD4 LYMPHOCYTE COUNT; EPIDEMIOLOGIC METHODS; FEMALE; HIV SEROPOSITIVITY; HIV-1; HUMANS; MALE; MIDDLE AGED;

EID: 15444379864     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Holmberg SD, Conley LJ, Luby SP, Cohn S, Wong LC, Vlahov D. Recent infection with human immunodeficiency virus and possible rapid loss of CD4 T lymphocytes. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 9:291-296.
2. Galai N, Lepri AC, Vlahov D, Pezzotti P, Sinicco A, Rezza G. Temporal trends of initial CD4 cell counts following human immunodeficiency virus seroconversion in Italy, 1985-1992. The Human Immunodeficiency Virus Italian Seroconversion Study. Am J Epidemiol 1996; 143:278-282.
3. Sinicco A, Fora R, Raiteri R. Is the clinical course of HIV-1 changing? Cohort study. BMJ 1997; 314:1232-1237.
4. Vanhems P, Lambert J, Guerra M, Hirschel B, Allard R. Association between the rate of CD4+ T cell decrease and the year of human immunodeficiency virus (HIV) type 1 seroconversion among persons enrolled in the Swiss HIV cohort study. J Infect Dis 1999; 180:1803-1808.
5. CASCADE Collaboration. Differences in CD4 cell counts at seroconversion and decline among 5739 HIV-1-infected individuals with well-estimated dates of seroconversion. J Acquir Immune Defic Syndr 2003; 34:76-83.
6. Rezza G. Determinants of progression to AIDS in HIV-infected individuals: an update from the Italian Seroconversion Study. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17 (Suppl 1):S13-S16.
7. Dorrucci M, Rezza G, Vlahov D, et al. Clinical characteristics and prognostic value of acute retroviral syndrome among injecting drug users. Italian Seroconversion Study. AIDS 1995; 9:597-604.
8. Vanhems P, Lambert J, Cooper DA. Severity and prognosis of acute human immunodeficiency virus type 1 illness: a dose-response relationship. Clin Infect Dis 1998; 26:314-322.
9. Keet IP, Krijnen P, Koot M, Lange JM, Miedema F, Goudsmit J, et al. Predictors of rapid progression to AIDS in HIV-1 seroconverters. AIDS 1993; 7:51-57.
10. Pezzotti P, Dorrucci M, Donisi A, et al. Sopravvivenza, progressione in AIDS e livello di immunosoppressione in persone HIV-positive prima e dopo l'introduzione della terapia anti-retrovirale di combinazione con tre o più farmaci (HAART). Epidemiol Prev 2003; 27:333-339.